LIFE - Atyr Pharma Inc
0.7927
-0.007 -0.833%
Share volume: 786,745
Last Updated: 03-26-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-13-2024 | 11-07-2024 | 03-13-2025 | 05-07-2025 | 08-07-2025 | 11-06-2025 | 03-05-2026 | |
| Assets | |||||||||
| Total Assets | 113.251 M | 105.939 M | 91.616 M | 96.830 M | 97.245 M | 101.534 M | 106.652 M | 93.003 M | |
| Current Assets | 96.916 M | 90.297 M | 76.317 M | 81.954 M | 83.271 M | 87.492 M | 93.014 M | 80.237 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 77.688 M | 71.677 M | 54.529 M | 61.070 M | 65.987 M | 63.126 M | 84.052 M | 67.944 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.808 M | 6.805 M | 11.458 M | 11.055 M | 10.362 M | 17.220 M | 6.150 M | 10.743 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.353 M | 5.184 M | 5.021 M | 4.850 M | 4.683 M | 4.526 M | 4.429 M | 4.263 M | |
| Other Assets | 10.982 M | 10.458 M | 10.278 M | 10.026 M | 9.291 M | 9.516 M | 9.209 M | 8.503 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 113.251 M | 105.939 M | 91.616 M | 96.830 M | 97.245 M | 101.534 M | 106.652 M | 93.003 M | |
| Total liabilities | 28.969 M | 24.515 M | 26.477 M | 26.998 M | 22.383 M | 26.878 M | 26.608 M | 25.715 M | |
| Total current liabilities | 15.979 M | 11.837 M | 14.118 M | 14.967 M | 10.683 M | 15.531 M | 15.678 M | 15.148 M | |
| Accounts Payable | 4.893 M | 1.255 M | 3.949 M | 4.323 M | 1.531 M | 3.881 M | 4.064 M | 3.891 M | |
| Other liabilities | 11.693 M | 11.514 M | 11.331 M | 11.144 M | 10.953 M | 10.745 M | 10.532 M | 10.308 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.693 M | 11.514 M | 11.331 M | 11.144 M | 10.953 M | 10.745 M | 10.532 M | 10.308 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 84.466 M | 81.608 M | 65.325 M | 70.019 M | 75.050 M | 74.845 M | 80.235 M | 67.480 M | |
| Common stock | 568.138 M | 581.596 M | 582.368 M | 602.105 M | 622.042 M | 641.377 M | 672.437 M | 673.652 M | |
| Retained earnings | -483.514 M | -499.820 M | -517.079 M | -532.046 M | -546.926 M | -566.457 M | -592.201 M | -606.164 M |